Shil Patel

Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells

G. Mcallister, G. Seabrook, S. Freedman, 1993, FEBS letters.

Stable expression of human D3 dopamine receptors in GH4C1 pituitary cells

G. Mcallister, G. Seabrook, S. Freedman, 1992, FEBS letters.

Functional expression of human D3 dopamine receptors in differentiated neuroblastoma × glioma NG108–15 cells

J. Kemp, G. Mcallister, G. Seabrook, 1994, British journal of pharmacology.

Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression

P. Whiting, G. Mcallister, S. Biello, 2005, Neuropharmacology.

An in vivo binding assay to determine central α1-adrenoceptor occupancy using [3H]prazosin

P. Hutson, S. Patel, Smita Patel, 2001 .

3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor.

P D Leeson, P. Leeson, C. Ragan, 1996, Journal of medicinal chemistry.

2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor.

J. G. Neduvelil, J. Castro, S. Patel, 2000, Bioorganic & medicinal chemistry letters.

Antinociceptive and toxic effects of (+)‐epibatidine oxalate attributable to nicotinic agonist activity

J. Traynor, S. Fletcher, S. Freedman, 1994, British journal of pharmacology.